The pyruvate kinase isoenzyme M2 (Tu M2-PK) as a tumour marker for renal cell carcinoma: Original article

European Journal of Cancer Care

Volumn 16, Issue 4, 2007, Pages 333-337

  Weinberger, R ^a   Appel, B ^b   Stein, A ^b   Metz, Y ^b   Neheman, A ^b   Barak, M ^a  

^a CLALIT HEALTH SERVICES   (Israel)

^b CARMEL MEDICAL CENTER   (Israel)

Author keywords

Area under the curve; Pyruvate kinase isoenzymes; Receiver operating characteristic analysis; Renal cell carcinoma; Tu M2 PK; Tumour marker

Indexed keywords

PYRUVATE KINASE; TUMOR MARKER;

AGED; ARTICLE; BLOOD; CANCER STAGING; FEMALE; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; METHODOLOGY; MIDDLE AGED; ROC CURVE; SENSITIVITY AND SPECIFICITY;

AGED; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PYRUVATE KINASE; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 34250869086     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2006.00753.x     Document Type: Article

References (21)

1. Board M., Humm S. Newsholme E.A. (1990) Maximum activities of key enzymes of glycolysis, glutaminolysis, pentose phosphate pathway and tricarboxylic acid cyclein normal, neoplastic and suppressed cells. Biochemical Journal 265, 503 509.
2. Brinck U., Eigenbrodt E., Oehmke M. Mazurek S. (1994) L- and M2- pyruvate kinase expression in renal cell carcinoma and their metastases. Virchows Archiv 424, 177 185.
3. Cerwenka H., Aigner R., Bacher H., Werkgartner G., El-Shabrawi A., Quehenberger F. Mischinger H.J. (1999) TUM2-PK (pyruvate kinase type tumor M2), CA19-9 and CEA in patients with benign, malignant and metastasizing pancreatic lesions. Anticancer Research 19, 849 852.
4. Eigenbrodt E., Reinacher M., Scheefers-Borchel U., Scheefers H. Friis R. (1992) Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells. Critical Reviews in Oncogenesis 3, 91 115.
5. Eigenbrodt E., Basenau D., Holthusen S., Mazurek S. Fischer G. (1997) Quantification of tumor type M2 pyruvate kinase in human carcinomas. Anticancer Research 17, 3153 5156.
6. Godley P.A. Ataga K.I. (2000) Renal cell carcinoma. Current Opinion in Oncology 12, 260 264.
7. Hegele A., Varga Z., Kosche B., Stief T., Heidenreich A. Hofmann R. (2003) Pyruvate kinase type tumor M2 in urological malignancies. Urologia Internationalis 70, 55 58.
8. Hugo F., Fischer G. Eigenbrodt E. (1999) Quantitative detection of Tumor M2-PK in serum and plasma. Anticancer Research 19, 2 2758.
9. Landis S.H., Murray T., Bolden S. Wingo P.A. (1999) Cancer statistics. CA: A Cancer Journal for Clinicians 49, 8 31.
10. Nicol D. (2000) Issues in the diagnosis of renal cell carcinoma. BJU International 86, 298 303.
11. Oremek G.M., Eigenbrodt E., Radle J., Zeuzem S.T. Seiffert U.B. (1997) Value of the serum levels of the tumor marker Tu M2-PK in pancreatic cancer. Anticancer Research 17, 3031 3034.
12. Oremek G.M., Teigelkamp S., Kramer W., Eigenbrodt E. Usadel K.H. (1999) The pyruvate kinase isoenzyme tumor M2 as a tumor marker for renal carcinoma. Anticancer Research 19, 2599 2602.
13. Oremek G.M., Sapoutzis N., Kramer W., Bickeboller R. Jonas D. (2000) Values of tumor M2 (Tu M2-PK) in patients with renal carcinoma. Anticancer Research 20, 5095 5098.
14. Roigas J., Schulze G., Raytarowski S., Jung K., Schnorr D. Loening S.A. (2001) Tumor M2 pyruvate kinase in plasma of patients with urological tumors. Tumor Biology 22, 282 285.
15. Roigas J., deger S., Schroeder J., Wille A., Turk I., Brux B., Jung K. Loening S.A. (2003) Tumor type M2 pyruvate kinase expression in metastatic renal carcinoma. Urological Research 31, 358 362.
16. Scheefers-Borchel U., Scheefers H., Michel A., Will H., Fischer G., Basenau D., Dahlmann N., Laumen R., Mazurek S. Eigenbrodt E. (1994) Quantitative determination (ELISA) of pyruvate kinase type tumor M2- A new tumor marker. In : Current Tumor Diagnosis: Applications, Clinical Relevance, Research Trends (ed. Klapdor R.), pp. 365 368. W Zuckschwerdt Verlag, Munich, Germany.
17. Silver D.A., Morash C., Brenner P., Campbell S. Russo P. (1997) Pathologic findings at the time of nephrectomy for renal mass. Annals of Surgical Oncology 4, 570.
18. Van Brussel J.P. Mickisch G.H.J. (1999) Prognostic factors in renal cell and bladder cancer. BJU International 83, 902 903.
19. Varga Z., Hegele A., Stief T., Heidenreich A. Hofmann R. (2002) Determination of pyruvate kinase type tumor M2 in human renal cell carcinoma: a suitable tumor marker? Urological Research 30, 122 125.
20. Vogelzang N.J. (1998) Kidney cancer. Lancet 352, 1691 1696.
21. Wechsel H.W., Petri E., Bichler K.H. Feil G. (1999) Marker for renal cell carcinoma. The dimeric form of pyruvate kinase type M2. Anticancer Research 19, 2583 2590.